Phase I Study of mPEG-R-Crisantaspase Given IV
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Pr Gilles Salles, MD
Centre Hospitalier Lyon Sud -Chemin du Grand Revoyet
Principal Investigator - Xavier Thomas, MD
Centre Hospitalier Lyon Sud - Chemin du Grand Revoyet
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre Henri Becquerel
Rouen, Cedex, France
- Hôpital Henri Mondor
Créteil, France
- Hôpitaux Du Chu de Nantes
Nantes, France
- Hospices Civils de Lyon
Pierre-Bénite, France
- Institut Claudius Regaud
Toulouse, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2012
- Primary completion
- 28 Feb 2015
- Completion
- 28 Feb 2015
- Last update posted
- 7 May 2015
- Registered enrollment
- 36
- Registry id
- NCT01551524
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.